Attenuation of Lysophosphatidylcholine-Induced Suppression of ANP Release from Hypertrophied Atria

Hypertension

Volumn 43, Issue 2 I, 2004, Pages 243-248

  Han, Jeong Hee ^a   Cao, Chunhua ^a   Kim, Soo Mi ^a   Piao, Feng Lian ^a   Kim, Suhn Hee ^a,b  

^a Chonbuk National University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

Calcium; Hypertension; Hypertrophy; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; FATTY ACID DERIVATIVE; LYSOPHOSPHATIDYLCHOLINE; MONOCROTALINE; OLEOYLLYSOLECITHIN; PALMITOYLLYSOLECITHIN; PHOSPHOLIPID; PHOSPHOLIPID DERIVATIVE; STEAROYLLYSOPHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BALANCE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART ATRIUM ENLARGEMENT; HEART ATRIUM HYPERTROPHY; HEART BEAT; HEART MUSCLE CELL; HEART MUSCLE PERFUSION; HEART VENTRICLE OVERLOAD; HEMODYNAMICS; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PULSE PRESSURE; RADIOIMMUNOASSAY; RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CALCIUM; CARDIOMEGALY; CELLS, CULTURED; CULTURE TECHNIQUES; HEART ATRIA; LYSOPHOSPHATIDYLCHOLINES; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0842267829     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000107779.92645.89     Document Type: Article

References (37)

1. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotaxic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA. 1988;85:2805-2809.
2. Otani H, Prasad MR, Jones RM, Das DK. Mechanism of membrane phospholipid degradation in ischemic-reperfused rat hearts. Am J Physiol. 1989;257:H252-H258.
3. Sedlis SP, Hom M, Sequeira JM, Esposito R. Lysophosphatidylcholine accumulation in ischemic human myocardium. J Lab Clin Med. 1993;121:111-117.
4. Sedlis SP, Hom M, Sequeira JM, Tritel M, Gindea A, Ladenson JH, Jaffe AS, Esposito, R. Time course of lysophosphatidylcholine release from ischemic human myocardium parallels the time course of early ischemic ventricular arrhythmia. Coron Artery Dis. 1997;8:19-27.
5. Sedlis SP, Sequeira JM, Altszuler HM. Coronary sinus lysophosphatidylcholine accumulation during rapid atrial pacing. Am J Cardiol. 1990;66:695-698.
6. + channels of guinea-pig ventricular myocytes. Cardiovasc Drugs Ther. 1993;7:575-584.
7. Kiyosue T, Arita M. Effects of lysophosphatidylcholine on resting potassium conductance of isolated guinea pig ventricular cells. Pflugers Arch. 1986;406:296-302.
8. Watson CL, Gold MR. Lysophosphatidylcholine modulates cardiac I(Na) via multiple protein kinase pathways. Circ Res. 1997;81:387-395.
9. Corr PB, Snyder DW, Cain ME, Crafford WA, Gross RW, Sobel BE. Electrophysiological effects of amphiphiles on canine Purkinje fibers: implications for dysrhythmia secondary to ischemia. Circ Res. 1981;49:354-263.
10. Snyder DW, Crafford WA, Glashow JL, Rankin D, Sobel BE, Corr PB. Lysophosphoglycerides in ischemic myocardium effluents and potentiation of their arrhythmogenic effects. Am J Physiol. 1981;241: H700-H707.
11. Giffin M, Arthur G, Choy PC, Man R. Lysophosphatidylcholine metabolism and cardiac arrhythmias. Can J Physiol Pharmacol. 1988;66:185-189.
12. 2+ accumulation in rat cardiac myocytes. Am J Physiol. 1983;244:H32-H38.
13. Woodley SL, Ikenouchi H, Barry WH. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma. J Mol Cell Cardiol. 1991;23:671-680.
14. Han JH, Cao C, Kim SZ, Cho KW, Kim SH. Decreases in ANP secretion by lysophosphatidylcholine through protein kinase C. Hypertension. 2003;41:1380-1385.
15. 2+ environment on atrial natriuretic factor release. Am J Physiol. 1989;256: H1588-H1594.
16. Cho KW, Kim SH, Seul KH, Hwang YH, Kook YJ. Effect of extracellular calcium depletion on the two-step ANP secretion in perfused rabbit atria. Regul Peptides. 1994;52:129-137.
17. Ruskoaho H, Toth M, Lang RE. Atrial natriuretic peptide secretion: synergistic effect of phorbol ester and A23187. Biochem Biophys Res Commun. 1985;133:581-588.
18. 2+ concentration on stretch-augmented natriuretic peptide secretion by rat atria. Am J Physiol. 1991;260:C756-C762.
19. Gwathmey JK, Morgan JP. Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res. 1985;57:836-843.
20. Steenberger C, Murphy E, Levy L, London RE. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res. 1987;60:700-707.
21. Gwathmey JK, Copleas L, Mackinnon R, Schoen FJ, Felman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61:70-76.
22. Limas CJ, Olivari MT, Goldenberg IF, Levine TB, Benditt DG, Simon A. Calcium uptake by cardiac sarcoplasmatic reticulum fractions in human dilated cardiomyopathy. Cardiovasc Res. 1987;21:601-605.
23. Grinwald PM, Nayler WG. Calcium entry in the calcium paradox. J Mol Cell Cardiol. 1981;13:867-880.
24. Franch RM, Hutchinson EC, Jones AM. Ventricular atrial natriuretic factor in the cardiomyopathic hamster model of congestive heart failure. Circ Res. 1988;62:31-36.
25. Lee KC, Lappe RW. Hypotensive response to atrial natriuretic factor in conscious chronic pulmonary hypertensive rats. Eur J Pharmacol. 1988;158:153-156.
26. Hirata Y, Suzuki E, Hayakawa H, Matsuoka H, Sugimoto T, Kojima M, Kangawa K, Matsuo H. Role of endogenous ANP in sodium excretion in rats with experimental pulmonary hypertension. Am J Physiol. 1992;262: H1684-H1689.
27. Kim SH, Lee KS, Kim YA, Seul KH, Kim SZ, Cho KW. Accentuation of ANP secretion to endothelin-1 in hypertrophied atria. Regul Peptides. 2001;102:21-29.
28. Kim SH, Han JH, Lim SH, Lee SJ, Kim SZ, Cho KW. Attenuation of inhibitory effect of CNP on the secretion of ANP from hypertrophied atria. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1456-R1463.
29. Cho KW, Seul KH, Kim SH, Seul KM, Ryu H, Koh GY. Reduction volume dependence of immunoreactive atrial natriuretic peptide secretion in isolated perfused rabbit atria. J Hypertens. 1989;7:371-375.
30. Cho KW, Kim SH, Hwang YH, Seul KH. Extracellular fluid translocation in perfused rabbit atria: implication in control of atrial natriuretic peptide secretion. J Physiol (Lond). 1993;468:591-607.
31. Lee SJ, Kim SZ, Cui X, Kim SH, Lee KS, Chung YJ, Cho KW. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling. Am J Physiol Heart Circ Physiol. 2000;278:H208-H221.
32. Wu R, Lemne C, de Faire U, Frostegard J. Antibodies to lysophosphatidylcholine are decreased in borderline hypertension. Hypertension. 2001;37:154-159.
33. Yu L, Netticadan T, Xu YJ, Panagia V, Dhalla NS. Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J Pharmacol Exp Ther. 1998;286:1-8.
34. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature. 1995;378:65-68.
35. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N. Hypertension cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A. 1997;94:14730-14735.
36. Clemo HF, Baumgarten CM. Atrial natriuretic factor decreases cell volume of rabbit atrial and ventricular myocytes. Am J Physiol. 1991;260:C681-C690.
37. Kim SZ, Cho KW, Kim SH. Modulation of endocardial natriuretic peptide receptors in right ventricular hypertrophy. Am J Physiol. 1999;277:H2280-H2289.